论文部分内容阅读
在中药抗血管瘤素(Chinese Anti-angiomatin)(CAA)治疗血管瘤的研究中,为了更广泛地为全国患者遥控治病,建立“家庭病床”。在长期专病诊疗实践中,摸索出了运载型中药抗血管瘤素(Carry-CAA),又称滤纸复原型中药抗血管瘤素(简称药滤纸)。鉴于其实用性,故介绍如下: 配制 CAA常用型(实为一种以中药鱼腥草为主的外用酊剂),将其自然挥发浓缩为原液十分之二,后将已浓缩液用吸管滴于实验用滤纸上即成(一般5cm×7cm滤纸上吸附2ml
In the study of traditional Chinese anti-angiomatin (CAA) treatment of hemangiomas, a “family bed” was established to remotely treat patients throughout the country. In the long-term specialized disease diagnosis and treatment practice, the carrier-type Chinese medicine anti-angiogenic factor (Carry-CAA) has been explored, and the filter paper-recovery type Chinese medicine anti-angioma factor (abbreviated as the drug filter paper) has been known. In view of its practicality, it is described as follows: Prepare a common type of CAA (in fact, a topical tincture mainly based on Houttuynia cordata), concentrate it as natural volatile matter to two-tenths of the original solution, and then use the straw to condense For experimental use on filter paper (generally adsorbed 2ml on 5cm×7cm filter paper